TY - JOUR
T1 - Opalescence Arising from Network Assembly in Antibody Solution
AU - Nakauchi, Yoshitaka
AU - Nishinami, Suguru
AU - Murakami, Yusuke
AU - Ogura, Toshihiko
AU - Kano, Hideaki
AU - Shiraki, Kentaro
N1 - Funding Information:
This work was partly supported by JSPS KAKENHI (grant number 18H02383).
Publisher Copyright:
© 2022 American Chemical Society.
PY - 2022/4/4
Y1 - 2022/4/4
N2 - Opalescence of therapeutic antibody solutions is one of the concerns in drug formulation. However, the mechanistic insights into the opalescence of antibody solutions remain unclear. Here, we investigated the assembly states of antibody molecules as a function of antibody concentration. The solutions of bovine gamma globulin and human immunoglobulin G at around 100 mg/mL showed the formation of submicron-scale network assemblies. The network assembly resulted in the appearance of opalescence with a transparent blue color without the precipitates of antibodies. Furthermore, the addition of trehalose and arginine, previously known to act as protein stabilizers and protein aggregation suppressors, was able to suppress the opalescence arising from the network assembly. These results will provide an important information for evaluating and improving protein formulations.
AB - Opalescence of therapeutic antibody solutions is one of the concerns in drug formulation. However, the mechanistic insights into the opalescence of antibody solutions remain unclear. Here, we investigated the assembly states of antibody molecules as a function of antibody concentration. The solutions of bovine gamma globulin and human immunoglobulin G at around 100 mg/mL showed the formation of submicron-scale network assemblies. The network assembly resulted in the appearance of opalescence with a transparent blue color without the precipitates of antibodies. Furthermore, the addition of trehalose and arginine, previously known to act as protein stabilizers and protein aggregation suppressors, was able to suppress the opalescence arising from the network assembly. These results will provide an important information for evaluating and improving protein formulations.
UR - http://www.scopus.com/inward/record.url?scp=85126577199&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126577199&partnerID=8YFLogxK
U2 - 10.1021/acs.molpharmaceut.1c00929
DO - 10.1021/acs.molpharmaceut.1c00929
M3 - Article
C2 - 35274955
AN - SCOPUS:85126577199
VL - 19
SP - 1160
EP - 1167
JO - Molecular Pharmaceutics
JF - Molecular Pharmaceutics
SN - 1543-8384
IS - 4
ER -